CN104583410B - 同时表达猪α干扰素和猪γ干扰素的重组腺病毒 - Google Patents

同时表达猪α干扰素和猪γ干扰素的重组腺病毒 Download PDF

Info

Publication number
CN104583410B
CN104583410B CN201380029029.6A CN201380029029A CN104583410B CN 104583410 B CN104583410 B CN 104583410B CN 201380029029 A CN201380029029 A CN 201380029029A CN 104583410 B CN104583410 B CN 104583410B
Authority
CN
China
Prior art keywords
interferon
foot
porcine
mouth disease
ifn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380029029.6A
Other languages
English (en)
Chinese (zh)
Other versions
CN104583410A (zh
Inventor
金秀美
朴锺贤
李光宁
高荣骏
李香心
申然景
金柄汉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
REPUBLIC OF KOREA (MANAGEMENT MINISTRY OF AGRICULTURE FOOD AND RURAL AFFAIRS)
Original Assignee
REPUBLIC OF KOREA (MANAGEMENT MINISTRY OF AGRICULTURE FOOD AND RURAL AFFAIRS)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by REPUBLIC OF KOREA (MANAGEMENT MINISTRY OF AGRICULTURE FOOD AND RURAL AFFAIRS) filed Critical REPUBLIC OF KOREA (MANAGEMENT MINISTRY OF AGRICULTURE FOOD AND RURAL AFFAIRS)
Publication of CN104583410A publication Critical patent/CN104583410A/zh
Application granted granted Critical
Publication of CN104583410B publication Critical patent/CN104583410B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C12N15/861—Adenoviral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CN201380029029.6A 2012-05-31 2013-05-31 同时表达猪α干扰素和猪γ干扰素的重组腺病毒 Active CN104583410B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20120058410A KR101329348B1 (ko) 2012-05-31 2012-05-31 돼지 인터페론 알파-돼지 인터페론 감마를 동시 발현하는 재조합 아데노바이러스
KR10-2012-0058410 2012-05-31
PCT/KR2013/004784 WO2013180501A1 (ko) 2012-05-31 2013-05-31 돼지 인터페론 알파-돼지 인터페론 감마를 동시 발현하는 재조합 아데노바이러스

Publications (2)

Publication Number Publication Date
CN104583410A CN104583410A (zh) 2015-04-29
CN104583410B true CN104583410B (zh) 2017-09-22

Family

ID=49673627

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380029029.6A Active CN104583410B (zh) 2012-05-31 2013-05-31 同时表达猪α干扰素和猪γ干扰素的重组腺病毒

Country Status (6)

Country Link
EP (1) EP2871240B1 (enExample)
JP (1) JP6386448B2 (enExample)
KR (1) KR101329348B1 (enExample)
CN (1) CN104583410B (enExample)
ES (1) ES2662948T3 (enExample)
WO (1) WO2013180501A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107286257A (zh) * 2017-08-09 2017-10-24 芜湖英特菲尔生物制品产业研究院有限公司 一种重组猪长效干扰素α及制备此长效干扰素的融合蛋白及其制备方法
KR102384683B1 (ko) * 2020-05-07 2022-04-11 대한민국 구제역 바이러스 억제 활성을 갖는 신규한 돼지 인터페론-알파 융합 단백질 및 이의 용도
CN115595312A (zh) * 2021-06-28 2023-01-13 中国农业大学（Cn） 一种重组腺病毒及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090269372A1 (en) * 2008-04-24 2009-10-29 Grubman Marvin J Enhanced Antiviral Activity Against Foot and Mouth Disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8058248B2 (en) * 2001-04-26 2011-11-15 The United States Of America As Represented By The Secretary Of Agriculture Foot and mouth disease virus vaccine comprising interferons
US7485291B2 (en) 2003-06-03 2009-02-03 Cell Genesys, Inc. Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
US7632509B2 (en) 2005-07-19 2009-12-15 Biosante Pharmaceuticals, Inc. Methods to express recombinant proteins from lentiviral vectors
BRPI0618441B8 (pt) * 2005-11-10 2021-07-27 Genvec Inc vetor adenoviral

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090269372A1 (en) * 2008-04-24 2009-10-29 Grubman Marvin J Enhanced Antiviral Activity Against Foot and Mouth Disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Coexpression of double or triple copies of the rabies virus glycoprotein gene using a‘self-c leaving ’2A peptide-based replication-defective human adenovirus serotype 5 vector.;Yeping Tan等;《Biologicals》;20101231;第38卷;第586-593页 *

Also Published As

Publication number Publication date
CN104583410A (zh) 2015-04-29
EP2871240A4 (en) 2016-01-27
EP2871240A1 (en) 2015-05-13
ES2662948T3 (es) 2018-04-10
WO2013180501A1 (ko) 2013-12-05
KR101329348B1 (ko) 2013-11-15
JP2015523858A (ja) 2015-08-20
EP2871240B1 (en) 2017-12-20
JP6386448B2 (ja) 2018-09-05

Similar Documents

Publication Publication Date Title
Rout et al. DNA vaccines encoding viral envelope proteins confer protective immunity against WSSV in black tiger shrimp
Fu et al. Protective immunity against infectious spleen and kidney necrosis virus induced by immunization with DNA plasmid containing mcp gene in Chinese perch Siniperca chuatsi
Tafalla et al. In vitro and in vivo differential expression of rainbow trout (Oncorhynchus mykiss) Mx isoforms in response to viral haemorrhagic septicaemia virus (VHSV) G gene, poly I: C and VHSV
JP4365023B2 (ja) 組換えブタ・アデノウイルス・ベクター
JP2022180463A (ja) 新規免疫化剤および使用方法
US20190151437A1 (en) Combination prime: boost therapy
WO2014063601A1 (zh) 诱导肿瘤特异性免疫的疫苗及其应用
CN104583410B (zh) 同时表达猪α干扰素和猪γ干扰素的重组腺病毒
Kim et al. Generation of G gene-deleted viral hemorrhagic septicemia virus (VHSV) and evaluation of its vaccine potential in olive flounder (Paralichthys olivaceus)
US20130058971A1 (en) Innoculation of recombinant viral vectors for rapid pre-exposure prevention and post-exposure protection against alphavirus-induced encephalitides
Ho et al. Double-stranded RNA confers both preventive and therapeutic effects against Penaeus stylirostris densovirus (PstDNV) in Litopenaeus vannamei
AU2002303503B2 (en) Foot and mouth disease virus vaccine
RU2013102413A (ru) Парапоксвирусные векторы
WO2017180616A1 (en) Dna constructs for manufacturing bio-therapeutic polypeptides for use in animal vaccines and therapeutics
CN105018512A (zh) 原核表达重组质粒pET-IFNγ、干扰素及用途
CN106916832B (zh) O型口蹄疫病毒重组核酸、重组疫苗株及其制备方法和应用
CN103589693A (zh) 一种表达ibdv vp2和法氏囊素三肽嵌合蛋白重组火鸡疱疹病毒
CN118161631A (zh) Ifi47的过表达质粒在抗丝状支原体丝状亚种感染中的应用
Kim et al. Generation of recombinant viral hemorrhagic septicemia viruses (VHSVs) harboring G gene of hirame rhabdovirus (HIRRV) and their ability to induce serum neutralization activity in olive flounder (Paralichthys olivaceus)
CN111588836B (zh) Cd40蛋白在制备提高罗非鱼抗链球菌免疫力的制品中的应用
KR101372364B1 (ko) 바이러스성 출혈성 패혈증 바이러스(vhsv) 감염 관련 신규한 유전자 및 바이러스성 출혈성 패혈증 바이러스 감염 억제용 조성물
Rojas et al. Adenovirus as tools in animal health
CN1757725A (zh) 能抑制口蹄疫病毒复制与感染的siRNA及其制备方法
Zheng et al. Immune efficacy of a genetically engineered vaccine against lymphocystis disease virus: analysis of different immunization strategies
CN102847169A (zh) 一种细胞肿大病毒dna疫苗及其构建和应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant